Med Pride Antifungal Cream Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Dabur India Limited is recalling 5,755 tubes of Med Pride 1% Clotrimazole Antifungal Cream due to CGMP deviations observed during FDA inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 1, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
Dabur India Limited is recalling Med Pride 1% Clotrimazole Antifungal Cream because of CGMP deviations, with deficiencies observed during an FDA inspection. The recall is classified as Class II and was initiated voluntarily by the firm.
Which Products Are Affected
The recall affects Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt. 1oz (28.3g), Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 524103 0244 2. A total of 5,755 tubes are involved, distributed US Nationwide. Affected lots are 001 through 013, all within expiry. The recall number is D-0638-2026.
What You Should Do
Consumers should contact the recalling firm for information on returns or refunds. The firm initiated notification via E-Mail.
Why This Matters
The recall involves over 5,700 tubes of an over-the-counter antifungal cream distributed nationwide.
Source
FDA recall number D-0638-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (943 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 1, 2026.
Frequently Asked Questions
Common questions about this FDA recall.